Miscellaneous / Anti-hepatitis Agents

Random Miscellaneous Quiz

Can you name the Anti-hepatitis Agents?

Quiz not verified by Sporcle

Forced Order
Challenge
Share
Tweet
Embed
HintAnswer
Use: HBV treatment adults only
SE: Anemia, neutropenia, dysgeusia, skin rash (esp. telaprevir), increased QT intervals (telaprevir)
Use: Effective suppression of HBV DNA, normalization of ALT & reducing HBeAg. Adults only
Entecavir (Baraclude) Class
Boceprevir Class
Contraindications: Hepatic decompensation, autoimmune dz, cardiac arrhythmia, pregnancy
Group MOA cont. (2) Ribonuclease L (activated by 2'5' oligo A): degrades mRNA.
PEG-IFN α-2a/2b class
Use: Lamivudine-resistant HBV. Adults only
IFN α-2a/2b class
P-kinetics: Natural. SC or IM
Use: The most potent anti-HBV agent. Adults only
P-kinetics: Prolonged intracellular half-life in HBV (than in HIV). Rapid oral absorption; eliminated unchanged. Used at lower doses for hepatitis than for AIDS.
P-kinetics:Oral bioavailability not affected by food. Emergence of resistance in long term use.
SE: Flu-like symptoms (fever, chills, myalgias, malaise). Neurotoxicity, myelosuppression, fatigue (chronic use). Transient hepatic enzyme elevation.
MOA: A prodrug of adefovir (adenosine analogue). Slows suppression of HBV DNA; least seroconversion
Drug MOA: PEG = polyethylene glycol
MOA: An adenosine analogue. Structurally similar to adefovir.
MOA: A thymidine analog
IFN alfacon-1 class
SE: Dose-dependent hemolytic anemia. Depression, fatigue, irritability, nausea, insomnia.
P-kinetics: Higher rate of complete response & less resistance vs. adefovir
Group MOA cont: Associated with mitochondrial DNA toxicity (by inhibiting DNA polymerase gamma)
P-kinetics: Synthetic (consensus). SC
SE: Nephrotoxicity (at high doses). Potential mitochondrial DNA toxicity
HintAnswer
Telbivudine (Tyzeka) Class
SE: Increased pancreatitis in HIV/HBV pts. Emergence of resistance (mutations of DNA polymerase)
Group MOA: 3 major enzymes are activated by IFN-JNK/STAT signaling pathway: (1) 2',5' oligo A synthase: produces 2'5' oligo A.
MOA: A cytosine analogue
P-kinetics: Clinical resistance is rare. Oral bioavailability decreased by food (taken w/ empty stomach). Renal elimination (serum concentration increased w/ altered kidney activit
MOA: Serine protease inhibitors. Bind to inhibit HCV non-structural protein NS3
Use: HBV: Safer for pts w/ decompensated liver dz. For both adults & peds
PEG-IFN α-2a Class
IFN α-2b Class
Adefovir dipivoxil (Hepsera) Class
Group MOA: Competively inhibit HBV DNA polymerase +/- incorporate into viral DNA causing chain termination. Phosphorylated to active forms intracellularly by cellular kinases.
P-kinetics: Lipophilic (pivoxil) moiety enhances oral bioavailability.
P-kinetics: Oral bioavailability increased with high-fat meal, decreased with antacid.
P-kinetics: Oral (TID). P450 substrates (potential rx interactions)
Group MOA cont. (3) Protein kinase (activated by dsRNA): phosphorylates/inhibits eIF-2, therefore blocking PRO synthesis
Group P-kinetics: Pills once a day for a year or longer
MOA: A prodrug (a guanosine nucleoside analogue). Phosphorylated by host cell enzymes; inhibits viral RNA-dependent polymerases.
P-kinetics: Slower clearance (less frequent dosing). Dosage adjustment is needed in renal dysfunction
SE: HA, fatigue, nausea. Potential mitochondrial toxicity (lactic acidosis & hepatic steatosis)
Use: Improve therapeutic response in pts (>18 yo) w/ HCV genotype 1 when combined w/ IFN/ribavirin
Lamivudine (3TC, Heptovir) Class
Tenofovir Class
Telaprevir Class
MOA: A guanisine analog. Inhibits all 3 functions of HBV RNA-dependent DNA polymerase (base priming, reverse transcription of the -strand, synthesis of the + strand of HBV DNA.
Contraindications: Pts w/ uncorrected anemia, ESRD, preggo. Teratogenic: avoid pregnancy for > 6 mos thereafter

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.